GOLDMAN SACHS GROUP INC - CORREVIO PHARMA CORP ownership

CORREVIO PHARMA CORP's ticker is CORV and the CUSIP is 22026V105. A total of 37 filers reported holding CORREVIO PHARMA CORP in Q4 2018. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
GOLDMAN SACHS GROUP INC ownership history of CORREVIO PHARMA CORP
ValueSharesWeighting
Q3 2018$49,00012,2740.00%
Other shareholders

There were no reported owners of CORREVIO PHARMA CORP in Q4 2018.

NameSharesValueWeighting ↓
View complete list of CORREVIO PHARMA CORP shareholders